Where does PeptiDream Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), PeptiDream Inc. ranks #24,982 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does PeptiDream Inc. hold?

PeptiDream Inc. holds 11 US utility patents granted between 2017 and 2025, spanning 9 technology areas.

What is PeptiDream Inc.'s Innovation Score?

PeptiDream Inc. has an Innovation Score of 30.9 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does PeptiDream Inc. focus on?

PeptiDream Inc.'s top technology area is C07K (Peptides) with 9 patents, ranking #972 of 3,615 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is PeptiDream Inc.'s patent grant rate increasing or decreasing?

PeptiDream Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for PeptiDream Inc.'s patents?

PeptiDream Inc.'s patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the PeptiDream Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

PeptiDream Inc.

USPTO PatentsView assignee record - 11 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Peptidream ranks #24,982 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 9 technology areas.

#24,982
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (30.9/100): 15.1
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24982 · Foreign Corporation #24,982 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,982/49,997
PHOTO-FINISH Parenteral
CPC-NARROW C07K · 9 areas
INNOV-THIN 30.9/100
CLAIMS-RICH 15.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Parenteral Technologies, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Peptidream’s 30.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (28%) Velocity 2.7 pts (9%) Breadth 10.6 pts (34%) Claim depth 9.1 pts (29%)

Qualcomm Incorporated · highest

85
PeptiDream · this assignee

31
3D Lighting… · lowest

7

What this shows Peptidream's Innovation Score is 30.9/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Peptidream?

Each dot is one of Peptidream’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Peptidream’s own 15.1 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Peptidream vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Peptidream's grants concentrate

PeptiDream Inc. is a focused PatentsView assignee: 9 CPC subclasses with 81.8% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2017. By volume, Peptidream sits between Parenteral Technologies, LLC and Pericom Semiconductor Corporation.

Peptidream's three-year grant acceleration

PeptiDream Inc. shows 2 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Parenteral

11
Parker Hannifin M…

11
Pattern Bioscience

11
Pendotech

11
Peptilogics

11
Perceptimed

11
Percutaneous Card…

11
Pericom Semicondu…

11
Peptidream ◀

11

What this shows PeptiDream holds 11 patents at rank #24,991, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near PeptiDream

By rank, the assignees closest to #24,991 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in PeptiDream's primary technology class.

Peptidream's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

PeptiDream Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2019	1	9.1%
2020	3	27.3%
2021	1	9.1%
2024	2	18.2%
2025partial year	3	27.3%

Which technologies does PeptiDream Inc. patent most?

C07K - Peptides 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07C - Acyclic OR Carbocyclic Compounds 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

PeptiDream Inc.'s patent record in context - here's where to go next.

PeptiDream Inc.'s lead technology class is C07K (Peptides), 81.8% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #24,982 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare PeptiDream Inc. against Parenteral Technologies, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.